2011 Cancer System Performance Report-Canadian Partnership Against Cancer

Blogger's Note: 

a specific search of the entire document 'ovary'/'ovarian' found 2 results in the form of references below: 

115.   Du Bois A, Rochon J, Lamparter C, Pfisterer J. 

Pattern of care and impact of participation in clinical studies on the outcomeof ovarian cancer.   Int J Gynecol Cancer. 2005;15:183-191.

("The purpose of this study was to evaluate the pattern and quality of care for ovarian cancer in German") 

                                       ~~~~~~~~~~~~~
116.  Du Bois A, Reuss A, Pujade Lauraine E, Harter P, Ray CoquardI, Pfisterer J.

Role of surgical outcome as prognostic factor inadvanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicentertrials. Cancer. 2009;115(6):1234-1244. 

                                             ~~~~~~~~~~~~


-----------------------------------------------------------

January 30, 2012

Measuring the performance of cancer control to maximize impact
The Partnership releases 2011 Cancer System Performance Report

Measuring the performance of the cancer system provides information that will inform initiatives to optimize quality in cancer control. The Partnership's System Performance Initiative is a collaboration with national and provincial partners to develop a consistent approach to evaluate, compare and identify areas for improvement across Canada's cancer control continuum. As part of this initiative, the Partnership is pleased to release the 2011 Cancer System Performance Report, an annual publication that helps shape this work.

Read more here.

Click here to read or download the 2011 System Performance Report. (pdf automatic download)

 ...............................................................................................

About the 2011 Report

This 2011 Report is the Partnership’s third report on the performance of the Canadian cancer system. The first two reports were produced in 2009 and 2010. As in the previous reports, this year’s is organized along the
dimensions of the cancer control continuum: Prevention, Screening, Diagnosis, Treatment, Research, Patient Experience (previously Supportive Care and Survivorship), and Long-Term Outcomes. Also bundled with the 2011 Report is Lung Cancer in Canada: A Supplemental System Performance Report.

A chapter titled Developmental and Interim Indicators has been added this year and includes indicators that are still under development and require some additional refinement or validation before they can be included as
performance indicators. This chapter also includes indicators that are not the preferred measures of performance or the specific domain but that are still useful to show until better indicators become available. Interim indicators
are also included because they are used internationally and allow for inter-jurisdictional comparisons.